Diabetic Polyneuropathy and Physical Activity in Type 1 Diabetes Mellitus: A Cross-Sectional Study.
IPAQ
diabetic polyneuropathy
physical activity
type 1 diabetes
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
18 Oct 2023
18 Oct 2023
Historique:
received:
09
09
2023
revised:
09
10
2023
accepted:
16
10
2023
medline:
28
10
2023
pubmed:
28
10
2023
entrez:
28
10
2023
Statut:
epublish
Résumé
The purpose of this study is to access whether a personal attitude to physical activity (PA) may influence the appearance of diabetic polyneuropathy (DPN) patients with well-controlled type 1 diabetes mellitus. Ninety patients attending the diabetes technology outpatient clinic were enrolled. DPN was investigated according to the Toronto consensus diagnostic criteria. PA was assessed using the International Physical Activity Questionnaire. PA was low in 21.1%, moderate in 42.2% and high in 36.7% of patients. According to Toronto criteria, we defined two categories: the first one with DPN absent or possible (57 (63.3%)) and a second one with DPN certain or probable (33 (36.7%)). The χ This study suggests that DPN is less present in type 1 diabetic patients with good metabolic control and a good personal habit of PA. Moderate-to-vigorous PA of at least 600 MET minutes/week might be a protective factor against DPN.
Sections du résumé
BACKGROUND
BACKGROUND
The purpose of this study is to access whether a personal attitude to physical activity (PA) may influence the appearance of diabetic polyneuropathy (DPN) patients with well-controlled type 1 diabetes mellitus.
METHODS
METHODS
Ninety patients attending the diabetes technology outpatient clinic were enrolled. DPN was investigated according to the Toronto consensus diagnostic criteria. PA was assessed using the International Physical Activity Questionnaire.
RESULTS
RESULTS
PA was low in 21.1%, moderate in 42.2% and high in 36.7% of patients. According to Toronto criteria, we defined two categories: the first one with DPN absent or possible (57 (63.3%)) and a second one with DPN certain or probable (33 (36.7%)). The χ
CONCLUSIONS
CONCLUSIONS
This study suggests that DPN is less present in type 1 diabetic patients with good metabolic control and a good personal habit of PA. Moderate-to-vigorous PA of at least 600 MET minutes/week might be a protective factor against DPN.
Identifiants
pubmed: 37892734
pii: jcm12206597
doi: 10.3390/jcm12206597
pmc: PMC10607752
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Diabetes Complications. 2012 Sep-Oct;26(5):424-9
pubmed: 22717465
Diabetes Care. 2006 Jun;29(6):1433-8
pubmed: 16732040
J Diabetes Complications. 2014 Sep-Oct;28(5):715-22
pubmed: 24929798
Trends Endocrinol Metab. 2019 May;30(5):286-298
pubmed: 30935671
World J Cardiol. 2016 Oct 26;8(10):575-583
pubmed: 27847558
J Diabetes Complications. 2014 Jan-Feb;28(1):17-21
pubmed: 24090951
Am J Epidemiol. 1990 Apr;131(4):633-43
pubmed: 2316495
Diabetes Metab Res Rev. 2011 Oct;27(7):620-8
pubmed: 21695763
Neurology. 1993 Apr;43(4):817-24
pubmed: 8469345
J Altern Complement Med. 2012 Dec;18(12):1172-8
pubmed: 22985218
Nat Rev Dis Primers. 2019 Jun 13;5(1):42
pubmed: 31197183
Diabetes Care. 2006 Jan;29 Suppl 1:S4-42
pubmed: 16373931
Diabetes Care. 2004 Aug;27(8):1980-4
pubmed: 15277427
Sports Med. 2014 Sep;44(9):1289-304
pubmed: 24927670
Diabetes Care. 1985 Mar-Apr;8(2):125-8
pubmed: 3996169
N Engl J Med. 2005 Jan 27;352(4):341-50
pubmed: 15673800
J Diabetes Complications. 2006 Jul-Aug;20(4):216-23
pubmed: 16798472
Mayo Clin Proc. 2013 Sep;88(9):942-51
pubmed: 24001486
Diabetes Care. 1997 May;20(5):836-43
pubmed: 9135952
Diabetes Care. 2016 Nov;39(11):2065-2079
pubmed: 27926890
JAMA. 2001 Sep 12;286(10):1218-27
pubmed: 11559268
Circulation. 2016 Mar 15;133(11):1058-66
pubmed: 26888765
Diabetes Care. 1994 Nov;17(11):1281-9
pubmed: 7821168
Diabetologia. 2010 Mar;53(3):458-66
pubmed: 19921145
N Engl J Med. 1995 Jul 13;333(2):89-94
pubmed: 7777034
Diabetes Care. 2010 Oct;33(10):2285-93
pubmed: 20876709
Lancet Diabetes Endocrinol. 2017 May;5(5):377-390
pubmed: 28126459
Phys Ther. 2008 Nov;88(11):1385-98
pubmed: 18801859